GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:22299032

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Zhang, Y, Morimoto, K, Danilova, N, Zhang, B and Lin, S (2012) Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS ONE 7:e30188

Abstract

Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome in which hematopoietic defects are the main cause of mortality. The most studied gene responsible for DC pathogenesis is DKC1 while mutations in several other genes encoding components of the H/ACA RNP telomerase complex, which is involved in ribosomal RNA(rRNA) processing and telomere maintenance, have also been implicated. GAR1/nola1 is one of the four core proteins of the H/ACA RNP complex. Through comparative analysis of morpholino oligonucleotide induced knockdown of dkc1 and a retrovirus insertion induced mutation of GAR1/nola1 in zebrafish, we demonstrate that hematopoietic defects are specifically recapitulated in these models and that these defects are significantly reduced in a p53 null mutant background. We further show that changes in telomerase activity are undetectable at the early stages of DC pathogenesis but rRNA processing is clearly defective. Our data therefore support a model that deficiency in dkc1 and nola1 in the H/ACA RNP complex likely contributes to the hematopoietic phenotype through p53 activation associated with rRNA processing defects rather than telomerase deficiency during the initial stage of DC pathogenesis.

Links

PubMed PMC3267717 Online version:10.1371/journal.pone.0030188

Keywords

Abnormalities, Multiple/genetics; Abnormalities, Multiple/pathology; Animals; Animals, Genetically Modified; Cell Cycle Proteins/genetics; Cell Cycle Proteins/physiology; Disease Models, Animal; Dyskeratosis Congenita/complications; Dyskeratosis Congenita/genetics; Dyskeratosis Congenita/metabolism; Dyskeratosis Congenita/pathology; Embryo, Nonmammalian; Embryonic Development/genetics; Embryonic Development/physiology; Hematologic Diseases/etiology; Hematologic Diseases/genetics; Hematologic Diseases/metabolism; Hematologic Diseases/pathology; Hematopoietic System/metabolism; Hematopoietic System/pathology; Nuclear Proteins/genetics; Nuclear Proteins/physiology; RNA Processing, Post-Transcriptional/genetics; RNA Processing, Post-Transcriptional/physiology; Ribonucleoproteins, Small Nucleolar/genetics; Ribonucleoproteins, Small Nucleolar/physiology; Tumor Suppressor Protein p53/metabolism; Tumor Suppressor Protein p53/physiology; Zebrafish; Zebrafish Proteins/genetics; Zebrafish Proteins/physiology

public



Cancel